Cochlioquinone A is the major component of a bioactive pigment isolated from Bipolaris leersia. It has been found to be an antagonist of the human chemokine receptor CCR5 in human immunodeficiency virus type 1 (HIV-1). It is anti-angiogenic and exhibits inhibitory activity against diacylglycerol acyltransferase and NADH ubiquinone reductase.
1. Jung, H.J., et al. 2003. Bioorg. Med. Chem. 11: 4743-4747. PMID: 14556789
2. Lee, H.B., et al. 2003. J. Antibiot. 56: 967-969. PMID: 14763563
3. Yoganathan, K., et al, 2004. J. Antibiot. 57: 59-63. PMID: 1503248
See how others have used Cochlioquinone A (CAS 32450-25-2). Click on the entry to view the PubMed entry .
PMID: # 14556789 Jung, H. et al. 2003. Bioorg Med Chem. 30: 1563-1566.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.